The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing ...

Endocrine-disease-focused Visen Pharmaceuticals is making its public market debut in Hong Kong, filing papers for an $86.5 ...

Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on Wednesday, April 2nd, IPO Scoop reports. The company plans to issue 2,700,000 shares at $7.50-$8.50 per share. The ...

DNA sequencing specialist’s decision to list in London in 2021 was seen as a victory for the market at the time ...

Discover how PomDoctor Limited aims to revolutionize China's telehealth industry with a $15M IPO, despite facing stiff ...

Icelandic biotechnology company Alvotech intends to explore the possibility of a Stockholm listing as it announced the acquisition of a Swedish research and development operation and drug candidate.

New breed of artificial intelligence startups will draw acquirers and IPO interest, venture investors predict.

The pharma is paying up to $1 billion to buy the Belgian startup, whose technology it sees as useful in treating cancer and ...